Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Garg

Showing results (251-260 of 292) with videos related to

Pageof 30
Sort By:
American Journal of Ophthalmology|September 5, 2020
The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsSamir N Patel, Jason Hsu, Meera D Sivalingam, et al.
Biomedical Journal|May 17, 2023
Real-world effectiveness of intravitreal dexamethasone implants - Comparison between eyes eligible and ineligible for clinical trials and their associated outcomesEugene Yu-Chuan Kang, Shih-Chieh Shao, Kai-Cheng Chang, et al.
Diabetes & Metabolism Journal|March 5, 2023
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsTzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 25, 2022
Survey of Vitreoretinal Specialists in the United States Regarding Telemedicine During the COVID-19 PandemicMichael N Cohen, Michael J Ammar, Raziyeh Mahmoudzadeh, et al.
Survey of Ophthalmology|April 27, 2022
Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyesGurkaran S Sarohia, Keean Nanji, Mohammad Khan, et al.
Retina (Philadelphia, Pa.)|May 13, 2025
Delayed-Onset Recurrent Retinal Detachment More Than One Year After Pneumatic Retinopexy, Scleral Buckle, or Vitrectomy for Primary Rhegmatogenous Retinal Detachment Repair: Incidence, Characteristics, and OutcomesTaku Wakabayashi, Catherine K Liu, Bita Momenaei, et al.
Current Eye Research|February 1, 2021
Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year PeriodMaitri Pancholy, Philip P Storey, Hannah J Levin, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 17, 2023
Neurotrophic keratopathy following rhegmatogenous retinal detachment surgeryRachel N Israilevich, Zeba A Syed, David Xu, et al.
Retina (Philadelphia, Pa.)|October 26, 2016
MICROBIOLOGIC SPECTRUM AND VISUAL OUTCOMES OF ACUTE-ONSET ENDOPHTHALMITIS UNDERGOING THERAPEUTIC PARS PLANA VITRECTOMYJayanth Sridhar, Yoshihiro Yonekawa, Ajay E Kuriyan, et al.
Journal of Personalized Medicine|March 29, 2023
The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic PatientsEugene Yu-Chuan Kang, Tzu-Yi Lin, Sunir J Garg, et al.
Pageof 30

Showing results (251-260 of 292) with videos related to

Sort By:
Pageof 30
American Journal of Ophthalmology|September 5, 2020
The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsSamir N Patel, Jason Hsu, Meera D Sivalingam, et al.
Biomedical Journal|May 17, 2023
Real-world effectiveness of intravitreal dexamethasone implants - Comparison between eyes eligible and ineligible for clinical trials and their associated outcomesEugene Yu-Chuan Kang, Shih-Chieh Shao, Kai-Cheng Chang, et al.
Diabetes & Metabolism Journal|March 5, 2023
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsTzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 25, 2022
Survey of Vitreoretinal Specialists in the United States Regarding Telemedicine During the COVID-19 PandemicMichael N Cohen, Michael J Ammar, Raziyeh Mahmoudzadeh, et al.
Survey of Ophthalmology|April 27, 2022
Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyesGurkaran S Sarohia, Keean Nanji, Mohammad Khan, et al.
Retina (Philadelphia, Pa.)|May 13, 2025
Delayed-Onset Recurrent Retinal Detachment More Than One Year After Pneumatic Retinopexy, Scleral Buckle, or Vitrectomy for Primary Rhegmatogenous Retinal Detachment Repair: Incidence, Characteristics, and OutcomesTaku Wakabayashi, Catherine K Liu, Bita Momenaei, et al.
Current Eye Research|February 1, 2021
Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year PeriodMaitri Pancholy, Philip P Storey, Hannah J Levin, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 17, 2023
Neurotrophic keratopathy following rhegmatogenous retinal detachment surgeryRachel N Israilevich, Zeba A Syed, David Xu, et al.
Retina (Philadelphia, Pa.)|October 26, 2016
MICROBIOLOGIC SPECTRUM AND VISUAL OUTCOMES OF ACUTE-ONSET ENDOPHTHALMITIS UNDERGOING THERAPEUTIC PARS PLANA VITRECTOMYJayanth Sridhar, Yoshihiro Yonekawa, Ajay E Kuriyan, et al.
Journal of Personalized Medicine|March 29, 2023
The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic PatientsEugene Yu-Chuan Kang, Tzu-Yi Lin, Sunir J Garg, et al.
Pageof 30